Anticancer agent 352
Anticancer agent 352 is a heterobifunctional anticancer compound. Anticancer agent 352 exhibits only weak antiproliferative activity against both ERα-overexpressing and non-overexpressing T-Rex 293 cells induced by Doxorubicin (HY-15142A). Anticancer agent 352 can be used in breast cancer-related research.
Nos produits utilisent uniquement pour la recherche. Nous ne vendons pas aux patients.
- CAS No.: 3099599-58-0
- Formule: C51H54N10O3S
- Masse moléculaire:887.10
-
Stockage:
Please store the product under the recommended conditions in the Certificate of Analysis.
To place orders, for customer services and technical support, please contact: MedChemExpress USA
Tel: 609-228-6898 E-mail: [email protected] [email protected]
-
Activité biologique
-
Chemical Information
- Pureté et documentation
- Références
-
Help & FAQs
Activité biologique
|
ERα |
Anticancer agent 352 (III-224) exhibits moderate antiproliferative activity against MCF7 cells (GI50 = 0.05-0.5 μM)[1].
Anticancer agent 352 exhibits only weak antiproliferative activity against both ERα-overexpressing and non-overexpressing T-Rex 293 cells induced by Doxorubicin (HY-15142A) (GI50 > 2.5 μM)[1].
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.
Chemical Information
-
CAS No. 3099599-58-0
-
Masse moléculaire 887.10
-
Formule C51H54N10O3S
-
SMILES
CC1=C(C)SC2=C1C(C3=CC=C(N4CCC(O)(CC4)CN5CCN(C6=CC=C([C@H]7C8=CC=C(O)C=C8CC[C@H]7C9=CC=CC=C9)N=N6)CC5)C=C3)=N[C@H](CC%10=NC=CO%10)C%11=NN=C(C)N2%11
-
Livraison
Room temperature in continental US; may vary elsewhere.
-
Stockage
Please store the product under the recommended conditions in the Certificate of Analysis.
Pureté et documentation
Références
Calculators
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)
Anticancer agent 352 Related Classifications
HY-184960 Related Classifications
Powered by Bioz